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Abstract  
Effective transplant-mediated repair of ischemic brain lesions entails extensive tissue 
remodeling, especially in the ischemic core. Neural stem cells (NSCs) are promising 
reparative candidates for stroke induced lesions, however, their survival and integration 
with the host-tissue post-transplantation is poor. In this study, we address this challenge by 
testing whether co-grafting of NSCs with olfactory ensheathing cells (OECs), a special type 
of glia with proven neuroprotective, immunomodulatory, and angiogenic effects, can 
promote graft survival and host tissue remodelling. Transient focal cerebral ischemia was 
induced in adult rats by a sixty-minute middle cerebral artery occlusion (MCAo) followed 
by reperfusion. Ischemic lesions were verified by neurological testing and magnetic 
resonance imaging (MRI). Transplantation into the globus pallidus of NSCs alone or in 
combination with OECs was performed at two weeks post-MCAo, followed by histological 
analyses at three weeks post-transplantation. We found evidence of extensive vascular 
remodelling in the ischemic core as well as evidence of NSC motility away from the graft 
and into the infarct border in severely lesioned animals co-grafted with OECs. These 
findings support a possible role of OECs as part of an in situ tissue engineering paradigm 
for transplant mediated repair of ischemic brain lesions. 
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Introduction 
Ischemic stroke is one of the leading causes of disability-adjusted life-years (DALYs) 
worldwide, i.e. the number of life-years lost due to premature death and years lived with 
disability adjusted for severity, and accounts for 80-85% of all stroke incidents [1]. 
Ischemic stroke is caused by embolic or thrombotic obstruction of blood supply to the 
brain. An ischemic event triggers a complex molecular cascade including impaired cellular 
energy metabolism, cell depolarization, excitotoxicity, and disruption of the blood–brain 
barrier [1]. Depending on the duration of the ischemic event, these pathophysiological 
changes can lead to extensive neuronal and glial cell injury and/or death, and axonal loss or 
demyelination, resulting in severe functional deficits [2]. The brain tissue where blood flow 
is most severely reduced comprises the ischemic core and is characterized by rapid 
pannecrosis. The ischemic core is surrounded by the ischemic penumbra, which represents 
salvageable tissue but only within a limited time frame [3]. At present, the only proven 
medical intervention for the treatment of acute stroke involves thrombolysis with tissue 
plasminogen activator and/or endovascular mechanical thrombectomy, and aims to dissolve 
the embolic or thrombotic obstruction. However, tissue plasminogen activator can only be 
administered within a maximum of 4.5 hours (h) after the onset of stroke [4], which 
effectively excludes more than 85% of stroke patients from this treatment. Cell replacement 
therapy in the sub-acute or chronic stage offers the option of extending the narrow 
therapeutic window while addressing a key constituent of stroke pathophysiology, namely 
the cell loss caused by ischemia. In this context, a number of studies have demonstrated the 
potential of stem cell treatment in promoting tissue remodeling in animal models of 
ischemic stroke injury [5-9].  
 
Neural stem cells (NSCs) are self-renewing multipotent progenitors that can differentiate 
into both neurons and glia, a property that renders them highly relevant for central nervous 
  4 
system (CNS) repair [10, 11]. However, NSC survival post-engraftment is generally poor, 
especially in the ischemic core of large lesions [12]. Olfactory ensheathing cells (OECs), 
the glia surrounding the primary olfactory neurons throughout their trajectory from the 
olfactory mucosa to the olfactory bulb glomeruli, possess several attributes that make them 
particularly interesting in the repair of CNS lesions [13]. OECs secrete a host of growth 
factors, including vascular endothelial growth factor (VEGF), brain-derived neurotrophic 
factor (BDNF), glial cell line-derived neurotrophic factor (GDNF), and nerve growth factor 
(NGF), all of which are important for neural, glial and endothelial cell function as 
demonstrated in a number of experimental studies [14-19]. Furthermore, compared to 
Schwann cells, OECs induce less astrocytic response in in vitro confrontation assays [20] as 
well as following transplantation into adult CNS white matter [21]. We have previously 
demonstrated the capacity of OECs to promote tissue remodelling, including axonal sparing 
and plasticity, neovascularization and remyelination after induced central axotomy [19], 
while a recent clinical report suggests that OECs combined with Schwann cell transplants 
can promote functional regeneration of supraspinal connections after spinal cord injury 
[22]. Furthermore, growing evidence from experimental studies suggests that apart from 
being neuroprotective to injured neurons, OECs interact with astrocytic processes to form 
pathways that can help bridge the lesion cavity by providing a microenvironment 
permissive to axonal growth, a mechanism described as the ‘pathway hypothesis’ by 
providing structural, as well as biochemical support [23, 24]. Taken together, the above 
attributes suggest that if OECs are co-engrafted with NSCs, they may enhance the viability 
and function of the NSC graft and synergistically act to achieve in situ tissue engineering 
after a focal ischemic lesion.  
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In this study, we used the middle cerebral artery occlusion (MCAo) model to induce 
transient focal cerebral ischemia in adult rats and investigated whether NSC and OEC co-
transplants engrafted in the basal ganglia can promote tissue remodelling.  
 
Materials and Methods  
Cell culture and labelling 
OECs from neonatal rats were purified as previously described [20]. Briefly, the olfactory 
bulbs of 4-5 P7 Sprague Dawley rats were harvested and finely chopped, then 
enzymatically digested in L-15 (Leibovitz) medium (Sigma), and triturated through a 26 
gauge needle. Dissociated cells were incubated in a cocktail of O4 (IgM at 1:4) and anti-
galactocerebroside (IgG3 at 1:2) primary antibodies (Clonetech), followed by their 
fluorochrome conjugated class specific secondary antibodies (Life Technologies). Further, 
dissociated cells were rinsed and then incubated in goat anti-mouse IgM phycoerythrin and 
goat anti-mouse IgG3 fluorescein secondary antibodies (1:100, Southern Biotech, 
Cambridge, UK). OECs were purified by fluorescence activated cell sorting (FACS) 
(Becton Dickenson, Oxfordshire, UK) by selecting for galactocerebroside-negative and O4-
positive cells. Subsequently, OECs were cultured in Dulbecco’s Modified Eagle’s Medium 
(DMEM) GlutaMAX® (Sigma-Aldrich Company Ltd., Dorset, UK) with 1.25% 
gentamicin (Sigma), and 5% FBS (Autogen Bioclear, Wiltshire, UK) on 13 µg/ml poly-L-
lysine- (PLL) (Sigma) coated 25cm2 flasks (Sigma). The cultures were supplemented with 
500 ng/ml fibroblast growth factor 2 (FGF2) (Peprotech, London, UK) 50 ng/ml heregulin 
(hrgβ1) (R&D Systems Europe Ltd, Abingdon, UK), and 10-6 M forskolin (Sigma). 
Finally, OECs were passaged at confluence. Purity of the OECs populations was assessed 
by p75NTR specific labelling and was always at 98-100%. In order to investigate the 
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distribution of OECs at the graft site, OECs were engineered to express enhanced green 
fluorescent protein (eGFP, Clontech, Living Colors). Shortly after purification, 
subconfluent cultures of OEC were infected overnight with transient supernatant taken from 
eGFP transfected phoenix cells, as previously described [17]. Transfection efficacy was 
determined by fluorescence microscopy of retrovirally labelled OEC cultures and was at 
70-80%.   
H9 (human embryonic) NSCs (GIBCO®, Invitrogen, Life Technologies, Carlsbad, CA, 
USA) were cultured in 75 cm2 flasks coated with CELLStart™, a xeno-free cell culture 
substrate (Invitrogen, life Life Technologies). The cultures were fed with Complete 
StemPro® serum-free NSC medium (Invitrogen, life Technologies), kept in a standard 
humidified air incubator with 5% CO2, at 37°C, and passaged twice at about 90% 
confluence before transplantation. Early passage (P3) primary NSCs at 90% confluence 
were stained with PKH26 cell linker kit (Sigma) immediately prior to in vitro co-culture 
studies or transplantation, as appropriate, according to the manufacturer’s instructions. 
To determine optimal seeding density (i.e. number of cells/cm2) for NSC-OEC co-cultures, 
a series of co-culture assays were performed at relative proportions of NSC:OEC of 70:30, 
50:50, and 30:70, in the presence of OEC and/or NSC culture media. 
Animal procedures 
All animal procedures were approved by the Norwegian ethics committee and were 
conducted in accordance with the relevant national, regional and site guidelines. Male 
Sprague Dawley rats (9 weeks old; 225-280 g, at start) were purchased from Scanbur AS.  
Cages were kept in a 12:12 h light/dark cycle, and animals had ad libitum access to food 
pellets and water.  
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Middle cerebral artery occlusion (MCAo) 
The animals were randomly assigned into two groups for surgery; (i) sham MCAo (n=5) 
and (ii) MCAo (n=30). Right middle cerebral artery occlusion (MCAo) was performed 
under anaesthesia with Hypnorm/Dormicum (Fluanizon/Fentanyl/Midazolam) using the 
intraluminal filament technique [25, 26].  The animals remained anaesthetized for 60 min 
when the monofilament was withdrawn to allow for reperfusion. Xylocaine spray 10mg/ml 
(Astra Zeneca) was topically applied to the incision before suturing and returning the 
animals to their cages, where they were kept under observation and allowed to wake up. 
Post-operative food intake was supported by administration of pellets soaked in Nutridrink 
(Nutricia). 
Verification of stroke-induced brain lesions  
Verification of stroke lesions included neurological scoring using the Bederson scale in 
combination with T2-weighted magnetic resonance imaging (MRI) obtained at 1 week 
post-injury (wpi). For MRI, the animals were placed prone on a dedicated water-heated bed 
within a 7T small animal scanner (Biospec 70/20 AS, Bruker Biospin MRI, Ettlingen, 
Germany) with water-cooled gradients (BGA-12S, 660 mT/m). An 86 mm volume 
resonator was used for radiofrequency (RF) transmission and a phased array rat head 
surface coil was used for RF reception. T2-weighted images were obtained under isoflurane 
anaesthesia (2% isoflurane in 30% O2/70% N2) using a rapid acquisition with relaxation 
enhancement (RARE) sequence with effective echo time (TE) = 30 ms; repetition time 
(TR) = 3700 ms; number of averages (NA) = 8; Rare Factor = 8; field of view (FOV) = 
20.4 x 16 mm2; acquisition matrix 204 x 160; 32 coronal slices à 0.5 mm; scan time = 4m 
56s. The T2-weighted images were scored by a blinded observer with experience in 
evaluating rat brain MR images. Inclusion criteria for allocation into treatment groups were 
defined as: animals with observed hyperintensities in the ipsilateral striatum, or ipsilateral 
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cortex (S1 or S2), or ipsilateral thalamus, which also matched with a neurological score of 
>1 on the Bederson scale at 1wpi. Using these criteria, 17 (57 %) animals were included for 
treatment randomization. 
Intracranial cell transplantation 
Based on post-operative neurological assessment and MRI data obtained at 1w after 
MCAo, animals with confirmed ischemic injury were randomly assigned into three groups 
for intrastriatal cell transplantation at 2wpi, as follows: 1) untreated controls (n=4); 
injection of 3 µl saline, 2) NCS group (n=6); injection of 3 µl of 3 × 105 NSC suspension, 
and 3) NSC and OEC group (n=7); injection of 3 × 105 NSC-OEC suspension at a 
proportion of 50:50. For transplantation, the animals were placed in a rat head stereotactic 
frame (Kopf Instruments) under 1.5-2% isoflurane anaesthesia. Local anaesthesia was 
administered subcutaneously, before exposing the skull by midline incision. Injection 
coordinates were determined with reference to the Bregma, using the Paxinos Watson rat 
brain atlas (Elsevier) at AP -1.3, L -3.5, V -7.0, representing the ipsilesional globus 
pallidus, consistent with a previous study [7]. After making a burr hole, a total volume of 3 
µl of cell suspension (or saline) was injected at a rate of 1 µl/min using a Hamilton syringe 
attached to an UltraMicroPump (UMP3) with SYS-Micro4 Controller (World Precision 
Instruments Ltd, Hitchin, Herdfordshire, UK). To avoid reflux, at the end of the injection, 
the needle was left inside the skull for another 2 min before being slowly withdrawn. The 
burr hole was subsequently sealed with sterile bee’s wax and the incision sutured before the 
animals were returned to their cages. Immunosuppression was not considered necessary due 
to the relatively low immunogenicity of NSCs [27] and the fact that the OECs were 
homologously derived.  
4.2.4. Cylinder rearing test 
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The animals’ locomotor asymmetry was evaluated using the cylinder rearing test. Briefly, 
at 10 and 11 days post-injury (dpi), 4 days post-transplantation (dpx), and 21 dpx, animals 
were placed in a glass cylinder (67 cm tall, 15 cm diameter) and video recorded for five 
minutes (21). Three mirrors were arranged so that contacts between the forepaws and the 
cylinder wall could be monitored at all times. The videos were subsequently reviewed 
frame-by-frame separately by two observers blinded to experimental group assignment and 
the number of contacts between the forepaw and the cylinder wall were counted and 
registered as left (NL) or right (NR). Only contacts involving all digital pads and the palmar 
pads were registered. A normalized forepaw preference ratio (FP) was then calculated for 
each limb in each animal: !"#$#%& ×100 = 𝐿𝑒𝑓𝑡	𝑝𝑎𝑤	𝑟𝑎𝑡𝑖𝑜, or !6#$#%& ×100 =𝑅𝑖𝑔ℎ𝑡	𝑝𝑎𝑤	𝑟𝑎𝑡𝑖𝑜.  
Intracardial perfusion and tissue collection 
At 3 wpx, the animals were sedated with 3.5% isoflurane, given a lethal injection of 
Pentobarbital (1mL/kg), and exsanguinated by means of intracardial perfusion with 50 mL 
chilled phosphate buffered saline (PBS) solution followed by 50 ml 4% paraformaldehyde. 
The whole brain was then removed and post-fixed in 4% paraformaldehyde at 4°C 
overnight and cryoprotected by immersion in 30% sucrose for 2-3 days at 4°C before being 
embedded in OCT compound (BDH), frozen in liquid nitrogen and stored at -80°C.  
Volumetry  
Lesion volumes were calculated for each rat based on differences in hyperintensities in the 
T2 MR images using OsiriX (Pixmeo, Geneva, Switzerland) and an Intuos Creative Pen 
Tablet (Wacom Company, Ltd). The areas in each slice of the T2 scan from each rat that 
showed a hyperintense area relative to the contralateral hemisphere, were outlined using an 
Intuos Pen, before computing the ROI volume in OsiriX (Figure 1). Classification of lesion 
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severity based on lesion volume computations was as follows: (i) small lesion: volume <30 
µL; (ii) moderate lesion: volume 30 µL – 80 µL; and severe lesion: volume >80 µL.  
Immunohistochemical analyses of brain tissue 
50 µm-thick sections of post-mortem tissue were serially collected using a Leica CM3050S 
cryostat and placed on Superfrost® Plus glass slides (Fisher Scientific). 
Immunohistochemistry included the following steps: immersion in blocking solution 
consisting of 5% goat serum and 0.3% Triton X-100 in phosphate buffered saline (PBS) for 
1 h at room temperature (RT), followed by incubation with primary antibodies in a solution 
of 1% goat serum and 0.1% Triton-X in PBS at 4°C overnight. Primary antibodies 
included: anti-nestin rabbit polyclonal antibody (dilution 1:1000), anti-CD68 mouse 
monoclonal antibody (1:1000); anti-GFP rabbit polyclonal antibody (1:500), anti-collagen 
IV rabbit polyclonal antibody (1:300), and mouse monoclonal anti-human nuclei (HuNu) 
(Merck Millipore).  The sections were then washed three times in PBS before incubation 
with their class-specific secondary antibodies AlexaFluor 568 and AlexaFluor 488 
(Invitrogen, Life Technologies) with Hoechst (1:5000) for 3h at RT. The sections were 
subsequently washed in PBS, coverslipped with Fluorsave (Merck Millipore), and imaged 
on an Olympus Scan R or Zeiss Axiovert A1 fluorescent microscope. Images were post-
processed in Image J (U. S. National Institutes of Health, Bethesda, USA) for manual and 
automated cell counts.  
Statistical analyses 
Statistical differences between groups were determined by two-way ANOVA (not repeated 
measures), paired t-tests using a significance level of 95%, and Fisher’s exact test using 
Prism 7 for Mac OS X (GraphPad Software, Inc, San Diego, CA, USA). Post hoc power for 
paired t-tests was analysed using G*Power (Version 3.1.9.2).  
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Results 
Verification and evaluation of severity of stroke-induced lesions  
T2-weighted magnetic resonance imaging (MRI) at one week (w) post-injury (wpi), 
associated with a neurological score of >1 on the Bederson scale, verified the presence of 
MCAo-induced brain lesions and subsequent inclusion of the animals in the study. The T2-
weighted MR images revealed stroke-induced lesions in the form of hyperintensities 
observed primarily in the ipsilesional striatum, and/or frontal, parietal, and temporal cortex, 
but also in varying degrees in the thalamus, hypothalamus, cervicomedullary junction and 
substantia nigra. As expected, the extent and degree of severity of the ischemic lesions 
induced by MCAo varied largely between rats (Figure 1A-D), thus mimicking the clinical 
situation [25, 28]. 3D reconstruction of the T2-weighted MR images (Figure 1E, F) and 
volumetric analyses further confirmed the variability in lesion severity, showing lesion 
volumes ranging from 7.6 µl – 130.5 µl. For each experimental group the median and range 
(in brackets) of the lesion volumes were as follows: The saline group had a median of 113.7 
µl (96.8-130.5 µl); the NSC group had a median of 17.05 µl (10.7-20.0 µl); and the NSC-
OEC group had a median of 54.25 µl (7.6-128.2 µl).  
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Formation of NSC-OEC networks in vitro 
In vitro NSC and OEC co-culture assays revealed gradual formation of distinct OEC 
networks interlaced with NSCs (Figure 2). Optimal cell dispersal and survival were 
achieved with a proportion of 50:50 in NSC:OEC co-cultures fed with NSC media. 
Specifically, we found that this proportion resulted in homogeneous co-cultures in which 
both cells attached and displayed normal morphology, and where the cells covered the 
entire surface of the wells, without leaving any areas unpopulated and without any 
aggregation of either cell type in separate parts of the wells. Furthermore,  these co-cultures 
yielded average cell counts of NSCs and OECs (expressed as mean ± standard deviation per 
unit area) of 34,532 ± 3,369/cm2 and 19,021 ± 2,774/cm2, respectively, at 48h post-seeding. 
This was comparable to the cell counts obtained from control cultures of each cell type 
separately at the same time point (NSCs: 38,119 ± 2,208/cm2; OECs: 21,006  ± 4,595/cm2). 
Figure 1) A-D. Representative images showing variability of lesion severity after MCAo 
as revealed by T2-weighted MRI. A. Sham animal. B. Small lesion (volume <30 µl). C. 
Moderate lesion (volume 30 µl – 80 µl). D. Severe lesion (volume >80 µl). E,F. 3D 
reconstruction of MCAo-induced lesion volumes. The lesion volume for each rat was calculated 
by first outlining (green line) the hyperintense areas in each frame in the T2 images (E) and 
digitally constructing a 3D representation of the delineated lesion, as shown in F. 
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Cell survival, motility and vascular remodelling post-transplantation 
Contrary to the in vitro observations, we found little evidence of network formation in 
NSC-OEC grafts in situ at 3w post-transplantation (wpx) in the globus pallidus. Indeed, the 
two cell types appeared to form separate clusters, with OECs aggregating in the core of the 
graft and NSCs localised in the graft periphery (Figure 3 A-C). These observations were 
only made in animals with small ischemic lesions (lesion volume <30 µl), in which the 
basal ganglia were not severely affected.   
As expected, NSC and NSC-OEC graft survival was better in animals with less severe 
lesions. Relatively good survival was observed for both cell types in the NSC-OEC grafts, 
albeit with NSC numbers on average 63% ± 14.4 higher than those of OECs. In these 
animals, both types of cells appeared to form tight clusters within the original graft location 
Figure 2) Formation of OEC networks in co-culture with NSCs. OECs (green; GFP) form 
distinct networks in co-culture with NSCs (red; PKH26); Scale bar: 10 µm. 
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with OECs always aggregating in the centre of the graft (Figure 3A-C). NSC-OEC grafts 
appeared much less clustered and more dispersed in animals with moderate and severe 
lesions (lesion volumes 30 µl – 80 µl, and  >80 µl, respectively)  (Figure 3 D-F), while 
overall NSC survival in these animals was significantly higher in the NSC-OEC group 
compared to NSC only (average number of NSCs/counting frame NSC/OEC group 87.6 ± 
24.3, versus NSC group 31.3 ± 18.6; two-tailed p < 0.05; Fisher’s exact test).  
 
In general, OEC survival was relatively poorer than that of NSCs, especially in animals 
with severe lesions, in which very few OECs (<1% of transplanted cells) were found. In 
co-grafted animals with moderate lesions, the average proportion of OECs per counting 
frame was 43.8 ± 11%. However, overall NSC survival in co-grafted animals with small 
and moderate lesions tended to be better than that of OECs (p=0.054; Fisher’s exact test). 
It is not clear whether the relative absence of OECs from animals with severe lesions can 
be attributed to cell death or to possible migration away from the engraftment site post-
Figure 3) Representative images from animals with NSC-OEC co-grafts at 3w px. A-C. Clusters 
formed by the transplanted cells within the graft location in animals with small ischemic lesions; 
D-F. Motility of the engrafted cells and dispersal within the ispilesional striatum; A,D. OECs 
(green; GFP); B,E. NSCs (red; PKH26); C. Merge A,B; D. Merge D,E. Scale bar 50µm 
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transplantation. However, we did not find any evidence of OEC migration regardless of 
lesion severity. Instead, we found  notable NSC migration from the lesion core and into the 
infarct border in animals with moderate and severe lesions (Figure 4) as well as NSC 
migration from the graft site to the ipsilesional corpus callosum in animals with small 
lesions (Figure 5). Furthermore, immunostaining against nestin (Figure 5B) and anti-
human nuclei antibody (Figure 5C) revealed larger numbers of NSCs than originally 
indicated by the PKH26 stain (Figure 5A), suggesting that PKH26 staining may 
underestimate the survival and/or migration of the engrafted NSCs post-transplantation. 
Interestingly, extensive vascular remodelling in the lesion core was observed in animals 




Figure 4) NSC migration into the infarct border in severely lesioned animals. Nestin-positive 
(red) NSCs with elongated neurite projections (arrows) can be observed along the border 
between the ischemic core and infarct border, integrating with the latter. Microglia (green; 
CD68) can also be observed in the infarct border (blue: Hoechst; Scale bar 50µm).  





Figure 5) NSC migration along the ipsilesional corpus callosum in animals with small lesions. 
A. Migrating NSCs (PKH26: orange) along the corpus callosum; B. Immunostaining against 
nestin (green) reveals additional migrating NSCs to those indicated by PKH26 staining (orange). 
C. Anti-human nuclei antibody (purple: HuNu; blue: Hoechst). Scale bar 100µm. 
Figure 6) Vascular remodelling in the ischemic core of animals with severe lesions at 3 wpx. A. 
Evidence of extensive vascular remodelling as revealed by staining against Collagen IV (green) 
in the lesion core. Images B1-D1 on the right-hand column show higher magnification of 
corresponding areas boxed in B-D; (blue: Hoechst; scale bar 100µm). 
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Behavioural assessment 
To assess forelimb functional asymmetries, the Cylinder Rearing Test was administered on 
day 10, 11, 16, and 28 post MCAo. A two-way repeated measures ANOVA showed no 
significant effects between left versus right forelimb preference, nor across timepoints 
(F(2,14) = 3.631). Paired t-tests showed no significant differences in right or left forelimb 
use within each group between day 10 and 28, i.e. before and after treatment (p > 0.05) 
(Figure 7). Post hoc power analysis of results from the paired t-tests yielded very low 
power (π > 0.105). This was expected due to the low number of animals in each group. 
However, there was an increased left forepaw preference in the saline treated control group, 
indicative of a trend towards improvement (p = 0.295, η² = 0.744).  
 
Discussion 
The formation of OEC networks in the in vitro co-culture with NSCs may constitute a 
predictor of OEC function post-transplantation. In particular, the self-organization of OECs 
Figure 7) Results of lateral asymmetry test showing left forelimb versus right forelimb 
preference ratio on Day 10 post MCAo compared to Day 28. Data are presented as means ± 
standard error of the mean. Two-way  ANOVA (not repeated measures) did not find any 
significant differences between left and right forelimb, or between time points.  
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into relatively continuous elongated network-like structures in the culture seemed to 
partially recapitulate the natural orientation of these cells in their resident milieu, in which 
they align themselves with the axons of primary olfactory neurons [13]. Although we found 
no direct evidence of in situ OEC network formation post-transplantation, our results 
suggest a possible role of OECs in promoting tissue remodeling after stroke.  
In particular, the evidence of an extensive vascular network in the lesion core of severely 
lesioned animals co-grafted with OECs could be attributed to potential stimulation of 
angiogenesis through local VEGF secretion from the transplanted OECs. Similarly, the 
overall NSC survival in animals that received NSC-OEC grafts suggests potential 
neuroprotective effects of the OECs on the transplanted NSCs, possibly through secretion 
of neurotrophic factors and cytokines. This is in accordance with previous findings, 
showing optimal effects of co-grafting NSCs with OECs in terms of promoting NSC 
survival and neuronal restoration after experimental traumatic brain injury and Parkinson’s 
disease [29, 30] .  
Furthermore, our findings might be in agreement with the ‘pathway hypothesis’ [31], 
according to which OECs may promote remodeling of disrupted neuronal pathways by 
acting as bridges which provide structural and/or biochemical support to regenerating axons 
or cell transplants [32, 33].  
Specifically, we found evidence of NSC migration away from the graft, having moved from 
inside the lesion core and into the infarct border. Although we did not observe any OECs in 
the graft core or in the infarct border in these animals, the finding of a vascular network in 
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the lesion core, coupled to the presence of migrating nestin-positive NSCs in the infarct 
border, may constitute indirect proof of structural and biochemical support involving 
juxtacrine and/or paracrine effects attributable to the engrafted OECs. On the other hand, it 
would be difficult to justify the absence of OECs from these tissues as a result of potential 
cell death, given that the degree of vascular remodeling observed in the lesion core should 
also have supported the longer-term in situ survival of the engrafted OECs, in addition to 
that of the NSCs. Thus, one explanation could be that ability to detect the transplanted 
OECs based solely on the expression of the GFP reporter gene may be severely 
compromised, especially in animals with more severe ischemic lesions. This is because 
formation of the GFP fluorophore requires molecular oxygen to catalyze its 
posttranslational cyclization [34, 35], implying that this process may have been adversely 
affected by the hypoxic conditions prevailing in the lesion core post-transplantation, 
leading to gradual loss of GFP expression and, effectively, inability to retrieve it, even with 
the use of an anti-GFP antibody. An alternative explanation for the lack of observable 
OECs is that the cells may have ultimately migrated to other sites in the brain or entered the 
lateral ventricle, as previously reported for different intraparenchymal cell transplants after 
MCAo [36-38].   
Another interesting perspective is how NSCs together with OECs may synergistically 
support in situ tissue remodeling after stroke injury. In a similar way in which NSC survival 
and integration with the host tissue may be promoted by the presence of OECs in the graft, 
as observed in animals with less severe lesions, the relatively good survival of the OECs in 
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the same animals may in turn be attributed to trophic support by the transplanted NSCs 
[39]. Notwithstanding the fact that reduced lesion severity will have provided a more 
favorable microenvironment in the host parenchyma, OEC survival post-transplantation in 
lesioned CNS tissue is generally expected to be poor [40]. Thus survival of OECs in these 
tissues may have been promoted by the presence of NSCs in the graft. Furthermore, given 
that a less severe lesion would also involve a less hypoxic host microenvironment, GFP 
expression in the transplanted OECs may not have been particularly affected, thus resulting 
in improved detectability. Overall, the difficulty of detecting surviving OECs based on GFP 
expression, might have been circumvented with the use of an OEC-specific antibody. 
However, in the absence of an unequivocal marker for OECs [40, 41], further 
immunostaining (i.e. in addition to anti-GFP antibody) for the purpose of identifying more 
surviving/migrating OECs was not relevant. In addition to the above, the tendency for 
aggregation of both NSCs and OECs in the original graft location, as opposed to any 
observable homing to other parts of the brain, could be explained by lower host tissue 
inflammation. Especially with regard to NSC transplants, their recruitment to affected parts 
of the brain is mediated by an increase in chemokine and cytokine production in response 
to the ischemic lesion [42]. Clearly, this effect can be expected to be less pronounced in 
smaller lesions.  
Still, we found evidence of callosal migration in the form of NSC clusters aligned with the 
ipsilesional corpus callosum in animals with less severe lesions. Cross-callosal, 
transhemispheric migration has previously been reported, especially for bone-marrow 
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stromal cells. However, in those cases the stem cells were originally transplanted in the 
contralesional hemisphere after stroke induced injury [6, 43]. Furthermore, after ischemic 
lesion, intracortically transplanted NSCs have been shown to migrate away from the initial 
graft location and to align themselves with the corpus callosum [44]. These and other 
studies suggest that NSCs are able to migrate to parts of the brain remote from the original 
graft locations along white matter tracts. Notwithstanding the possibility that the observed 
NSCs aligned with the ipsilesional corpus callosum might be derived from a residual 
population at the dorsal end of the injection tract as a result of needle withdrawal post-
injection, the absence of a visible needle tract in the tissue and the fact that the NSCs are 
also localized in sections anterior to the transplantation site, suggest that their presence in 
the corpus callosum may be the result of migration away from the globus pallidus, i.e. the 
transplantation site. Considering the relatively small lesion severity, NSC migration along 
existing white matter tracts, irrespective of any synergistic effects mediated by OECs 
should be possible.    
The cylinder rearing test revealed no significant differences in the use of the contralesional 
(left) forepaw over time in either of the treatment groups, but indicated a trend towards 
improvement in the saline treated control group, which may be consistent with spontaneous 
functional recovery [45, 46]. The lack of improvement in forepaw preference after NSC or 
NSC-OEC transplantation is not surprising, considering that any functional benefits as a 
result of the treatment would be marginal, and thereby difficult to evaluate at 3wpx. 
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Furthermore, small group sizes, as here, are sensitive to type II errors, especially when 
considering both limb, group and time in the same analysis as in this study.  
 Moreover, systematic bias due to individual differences between rats’ preferred forelimb 
use cannot be excluded [47, 48]. Thus, although the cylinder test may be useful for 
verifying stroke-induced functional deficits, its value in the assessment of gain of function 
in the present study may be limited.  
Finally, a relevant point in the above discussion is the extent to which the choice of 
experimental model, i.e. 60-minute MCAo, may have impacted our findings. This specific 
model is well-characterized in the literature and has been used in a number of experimental 
studies of transient focal cerebral ischemia, including studies investigating intrastriatal stem 
cell transplantation [7, 49-52]. However, one challenge associated with the MCAo model is 
that it is known to result in lesions of variable severity [7, 52-54]. While this per se may be 
considered positive in terms of the extent to which the MCAo model can recapitulate the 
variability observed in stroke patients, such differences in lesion severity, coupled to the 
strict criteria which were applied for the inclusion of lesioned animals in the study, did 
result in relatively small group sizes. Another relevant point here is the randomization 
procedure for animal allocation into groups. On this occasion, the randomization process 
resulted in differences in lesion severity between groups. A pseudorandom allocation would 
have helped avoid this situation.  
Taken together, our findings demonstrated that co-transplantation of NSCs with OECs can 
promote vascular and/or tissue remodeling in the ischemic brain as a result of synergistic 
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effects of the two cell types. Clearly, this was contingent on the extent of lesion severity. 
However, an important finding in our study was the evidence of OEC effects on in situ 
remodeling in more severe ischemic lesions, which seems to be in agreement with the 
pathway hypothesis. Notwithstanding that the variability of lesion pathology between 
subjects in a given cohort post-MCAo may confound a thorough elucidation of the exact 
mechanisms involved, it is worth considering how future strategies for stroke repair may 
involve OECs as part of an in situ tissue engineering paradigm as an alternative to or in 
combination with other approaches, as for example tailored biomaterials [6, 7, 53, 55]. 
Such approaches, which incorporate state-of-the-art advances in the field [56] are highly 
promising with a view to preserving and/or restoring host tissue as well as optimizing 
implant-derived effects that enhance brain plasticity for functional restoration [6, 56].  
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